share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:擬議出售證券
美股SEC公告 ·  11/05 05:40

牛牛AI助理已提取核心訊息

Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 15,441 shares of common stock on 11/04/2024, as per the latest filing. The shares, valued at an aggregate market value of $134,093, were acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,728 shares by the officer in the past three months, which had gross proceeds of $14,318.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 15,441 shares of common stock on 11/04/2024, as per the latest filing. The shares, valued at an aggregate market value of $134,093, were acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,728 shares by the officer in the past three months, which had gross proceeds of $14,318.
arcutis biotherapeutics首席執行官Patrick Burnett計劃於2024年11月4日出售15,441股普通股,根據最新的備案。這些股份的總市值爲134,093美元,是在2024年11月1日通過arcutis biotherapeutics的限制性股票授予計劃獲得的。這筆交易是該首席執行官在過去三個月中進行的第二筆交易,之前一筆交易共售出1,728股,總收入達到14,318美元。
arcutis biotherapeutics首席執行官Patrick Burnett計劃於2024年11月4日出售15,441股普通股,根據最新的備案。這些股份的總市值爲134,093美元,是在2024年11月1日通過arcutis biotherapeutics的限制性股票授予計劃獲得的。這筆交易是該首席執行官在過去三個月中進行的第二筆交易,之前一筆交易共售出1,728股,總收入達到14,318美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。